← Back to Search

Behavioral Intervention

Army-SPRING for Suicide Prevention

Phase 1
Waitlist Available
Led By Lily Brown, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, quarterly, year 1, year 2

Summary

This trial will investigate how to support Suicide Intervention Officers in the Connecticut Army National Guard and determine if this support reduces the risk of suicide in their units.

Who is the study for?
This trial is for Suicide Intervention Officers in the Connecticut Army National Guard. It aims to support them in their role of providing suicide intervention, monitoring soldiers in crisis, and connecting them with resources.
What is being tested?
The study is testing a new support program called Army-SPRING against the current standard practice. The goal is to see if this additional support can help reduce suicide risks within military units.
What are the potential side effects?
Since this trial involves educational and supportive interventions rather than medical treatments, traditional physical side effects are not expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, quarterly, year 1, year 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, quarterly, year 1, year 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reach - Buddy
Reach - Interactions with soldiers involving discussions about suicide risk
Reach - Self
Secondary study objectives
Acceptability
Adoption
Appropriateness
+5 more
Other study objectives
Intentions, attitudes, norms
Organizational culture

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Army-SPRINGExperimental Treatment1 Intervention
Army-SPRING includes a package of implementation options to support implementation of ASIST
Group II: Risk Reduction Group (Control)Placebo Group1 Intervention
Risk Reduction Group is a mandated training from National Guard Service members

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,476 Total Patients Enrolled
Yale UniversityOTHER
1,930 Previous Clinical Trials
3,033,417 Total Patients Enrolled
Lily Brown, PhDPrincipal InvestigatorUniversity of Pennsylvania
Ashley Hagaman, PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
37 Total Patients Enrolled
~38 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top